Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Vitamin d and multiple sclerosis: correlation, causality, and controversy.
Evaluation of the impact of neutralizing antibodies on IFNβ response.
Expression of a single ICAMâ1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitis.
Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis.
Strength: A Relevant Link to Functional Performance in the Neurodegenerative Disease of Adrenomyeloneuropathy.
Prevalence of Multiple Sclerosis in Tuscany (Central Italy): A Study Based on Validated Administrative Data.
Mouse Hepatitis Virus infection remodels Connexin43 mediated gap junction intercellular communication both in vitro and in vivo.
Reversible pulmonary arterial hypertension associated with interferon-beta treatment for multiple sclerosis.
Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility.
Potassium channel antagonists 4-aminopyridine and the T-butyl carbamate derivative of 4-aminopyridine improve hind limb function in chronically non-ambulatory dogs; a blinded, placebo-controlled trial.
Antimalarial Drug Artemether Inhibits Neuroinflammation in BV2 Microglia Through Nrf2-Dependent Mechanisms.
Leukocyte Gene Expression and Plasma Concentration in Multiple Sclerosis: Alteration of Transforming Growth Factor-βs, Claudin-11, and Matrix Metalloproteinase-2.
Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome.
Fingolimod and cardiac risk: latest findings and clinical implications.
Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms.
High nationwide incidence of multiple sclerosis in sweden.
Multiparity in women with multiple sclerosis causes less long-term disability: Commentary.
Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.
Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
Cost-Utility Analysis of Natalizumab as First-Line Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis in the Brazilian Public Healthcare System.
Possible Relations Between Epstein-Barr Virus Past Infection and Classic Multiple Sclerosis in Guilan, Iran.
Sharing data from MS clinical trials: Opportunities, challenges, and future directions.
Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis?
The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population.
Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin.
Pages
« first
‹ previous
…
666
667
668
669
670
671
672
673
674
…
next ›
last »